We have located links that may give you full text access.
JOURNAL ARTICLE
PRACTICE GUIDELINE
No. 345-Primary Dysmenorrhea Consensus Guideline.
OBJECTIVE: This guideline reviews the investigation and treatment of primary dysmenorrhea.
INTENDED USERS: Health care providers.
TARGET POPULATION: Women and adolescents experiencing menstrual pain for which no underlying cause has been identified.
EVIDENCE: Published clinical trials, population studies, and review articles cited in PubMed or the Cochrane database from January 2005 to March 2016.
VALIDATION METHODS: Seven clinical questions were generated by the authors and reviewed by the SOGC Clinical Practice-Gynaecology Committee. The available literature was searched. Guideline No. 169 was reviewed and rewritten in order to incorporate current evidence. Recommendations addressing the identified clinical questions were formulated and evaluated using the ranking of the Canadian Task Force on Preventive Health Care.
BENEFITS, HARMS, AND COSTS: Primary dysmenorrhea is common and frequently undertreated. Effective therapy is widely available at minimal cost. Treatment has the potential to improve quality of life and to decrease time lost from school or work.
GUIDELINE UPDATE: This guideline is a revision and update of No. 169, December 2005.
SPONSORS: SOGC.
SUMMARY STATEMENTS: RECOMMENDATIONS.
INTENDED USERS: Health care providers.
TARGET POPULATION: Women and adolescents experiencing menstrual pain for which no underlying cause has been identified.
EVIDENCE: Published clinical trials, population studies, and review articles cited in PubMed or the Cochrane database from January 2005 to March 2016.
VALIDATION METHODS: Seven clinical questions were generated by the authors and reviewed by the SOGC Clinical Practice-Gynaecology Committee. The available literature was searched. Guideline No. 169 was reviewed and rewritten in order to incorporate current evidence. Recommendations addressing the identified clinical questions were formulated and evaluated using the ranking of the Canadian Task Force on Preventive Health Care.
BENEFITS, HARMS, AND COSTS: Primary dysmenorrhea is common and frequently undertreated. Effective therapy is widely available at minimal cost. Treatment has the potential to improve quality of life and to decrease time lost from school or work.
GUIDELINE UPDATE: This guideline is a revision and update of No. 169, December 2005.
SPONSORS: SOGC.
SUMMARY STATEMENTS: RECOMMENDATIONS.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app